Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Shilpa Medicare Limited (NSE: SHILPAMED), ISIN INE790G01031 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SHILPAMED last traded at ₹933.15 (-0.98%), with a 52-week range of ₹259.50 to ₹1095.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 40.13%, FIIs 12.11%, DIIs 8.26%, mutual funds 4.20%.
EquiSense Score (ECS): 73/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.